Thalidomide inhalation (Vicore Pharma)

N/A

Report date: 2024/04/02 14:24:47

Base Information

Drug NameThalidomide inhalation (Vicore Pharma)
Drug Alias NameInhaled IMID (Vicore Pharma)VP02 (Vicore Pharma)VP-02 (Vicore Pharma)
ClassificationSmall molecules > Molecular GlueSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-2 inhibitorsInterleukin-6 inhibitorsFibroblast growth factor 2 inhibitors +[8] 
TargetsInterleukin-2Interleukin-6Fibroblast growth factor 2 +[8] 
Therapy Area/IndicationsCoughIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesINIM Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesVicore Pharma Holding AB
Inactive CompaniesN/A
Active IndicationsCoughIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A